NCT06957756View on ClinicalTrials.gov

A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems

PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

June 27, 2026

Study Completion Date

June 29, 2026

Conditions
Hepatic Insufficiency
Interventions
DRUG

BI 1584862

BI 1584862

Trial Locations (3)

32808

RECRUITING

Omega Research Orlando, LLC, Orlando

78215

RECRUITING

American Research Corporation, San Antonio

85225

NOT_YET_RECRUITING

Arizona Clinical Trials, Chandler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06957756 - A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems | Biotech Hunter | Biotech Hunter